Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-22T07:02:38.641Z Has data issue: false hasContentIssue false
  • English
  • Français

Conclusion: Summary and Recommendations

Published online by Cambridge University Press:  07 November 2014

John W. Newcomer ,
Henry A. Nasrallah ,
Roger S. McIntyre ,
Charles H. Hennekens  and
Suzanne Vogel-Scibilia
Get access Rights & Permissions [Opens in a new window]

Extract

Cardiovascular disease (CVD) remains the number one cause of death in the United States and most developed countries and is expected to remain so for much of this century. Rates of obesity have increased 2–4-fold over the last 2 decades in the US and this condition is linked with early development of hypertension, hyperlipidemia, diabetes, and atherosclerosis. The prevalence of diabetes is also increasing, and the rise of diabetes in young people 18–29 years of age was 40% in the period between 1990 and 2001. The World Heart Federation (WHF) has estimated that CVD will become the number one cause of death in the world by 2020, surpassing infectious disease in developing countries. Metabolic disorders are on the rise in general. However, as highlighted in the discussions presented in this supplement, patients with serious mental illness appear to represent a special population who are particularly vulnerable, with rates that surpass the general population.

Type
Clinical Information Supplement
Information
CNS Spectrums , Volume 13 , supplement S10: Elevating the Standard of Care in the Management of Cardiometabolic Risk Factors in Patients with Mental Illness , June 2008 , pp. 13 - 14
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Heart Disease and Stroke Statistics - 2006 Update. American Heart Association. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3036355. Accessed November 15, 2007.Google Scholar
2. SoRelle, R. Global epidemic of cardiovascular disease expected by the year 2050. Circulation. 1999;100(20):e101.CrossRefGoogle ScholarPubMed
3. Mathers, CD, Lopez, AD, Murray, CJL. The burden of disease and mortality by condition: data, methods, and results for 2001. In: Global Burden of Disease and Risk Factors, 2006. Disease Control Priorities Project and the International Bank for Reconstruction and Development, The World Bank, the World Health Organization, and the Fogarty International Center of the National Institutes of Health. Available at: http://files.dcp2.org/pdf/GBD/GBD03.pdf. Accessed November 15, 2007.Google Scholar
4. Calderon, KS, Yucha, CB, Schaffer, SD. Obesity-related cardiovascular risk factors: intervention recommendations to decrease adolescent obesity. J Pediatr Nurs. 2005;20(1):3–14.CrossRefGoogle ScholarPubMed
5. Engelgau, MM, Geiss, LS, Saaddine, JB, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140(11):945–950.CrossRefGoogle ScholarPubMed
6. World Heart Federation. Frequently asked questions, 2006. World Heart Federation Web site. Available at: http://www.worldheart.org/press-faqs.php. Accessed February 7, 2007.Google Scholar
7. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421.CrossRefGoogle Scholar
8. Grundy, SM, Cleeman, JI, Merz, CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227–239.CrossRefGoogle ScholarPubMed
9. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry. 2004;65(2):267–272.CrossRefGoogle Scholar
10. Newcomer, JW, Nasrallah, HA, McIntyre, RS, Hennekens, CH, Vogel-Scibilia, S. Elevating the standard of care in the management of cardiometabolic risk factors in patients with mental illness. CNS Spectr. 2008;13(6 Suppl 10):3–4.CrossRefGoogle ScholarPubMed
11. Marder, SR, Essock, SM, Miller, AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161(8):1334–1349.CrossRefGoogle ScholarPubMed
12. Nasrallah, H, McIntyre, R, Hennekens, C, Vogel-Scibilia, S. Translating clinical data into practice: a call-to-action to raise the standard of care in the treatment of schizophrenia and bipolar disorder [transcript]. Presented at: American Psychiatric Association Media Briefing; Toronto, Canada.Google Scholar